InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.17−0.07 (-5.65%)
Close on Nov 13, 2026Market cap $84.58MP/E –Yield –
InflaRx enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
InflaRx's enterprise value was $61.53M on Nov 11, 2026, against $59.16M a year earlier. Over the last 5 years it ranged from $24.92M to $197.34M, with a median of $68.59M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $61.53M | +39.1% |
| 2025 | Dec 31, 2025 | $44.25M | -61.8% |
| 2024 | Dec 31, 2024 | $115.88M | +129.6% |
| 2023 | Dec 29, 2023 | $50.47M | -56.1% |
| 2022 | Dec 30, 2022 | $114.86M | +15.5% |
| 2021 | Dec 31, 2021 | $99.44M | +10.1% |
| 2020 | Dec 31, 2020 | $90.28M | +133.4% |
| 2019 | Dec 31, 2019 | $38.68M | -80.8% |
| 2018 | Dec 31, 2018 | $201.03M | – |
| 2017 | Dec 29, 2017 | -$34.95M | – |
See a number that looks wrong?